The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Navrotskiĭ A.N.

GBOU VPO "Omskaia gosudarstvennaia meditsinskaia akademiia" Minzdrava Rossii

Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis

Authors:

Navrotskiĭ A.N.

More about the authors

Journal: Therapeutic Archive. 2016;88(11): 149‑155

DOI: 10.17116/terarkh20168811149-155

Read: 2628 times

Contact the author
Table of contents

DIAGNOSTIC POSSIBILITIES OF METHODS FOR THE EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS
DIAGNOSTIC POSSIBILITIES OF METHODS FOR THE EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS

To cite this article:

Navrotskiĭ AN. Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis. Therapeutic Archive. 2016;88(11):149‑155. (In Russ.)
https://doi.org/10.17116/terarkh20168811149-155

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Mela­nonychia in children: on the way to reco­mmendations for mana­gement tactics. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):636-641
Connective tissue diseases: deve­lopment predictors, multimorbidity variants, physical treatment methods. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5):56-62
Using the PathVision.ai model of medi­cal deci­sion support in morphological diagnostics of prostate cancer in biopsy mate­rial. Russian Journal of Archive of Pathology. 2025;(6):34-41
Comparison of the effi­ciency of an AI-assisted model for morphokinetic and morphological human blastocyst sele­ction with the pre-implantation gene­tic testing. Russian Journal of Human Reproduction. 2025;(6):75-84
Expe­rimental models of sali­vary gland damage. Review of morphological, functional, and mole­cular aspe­cts. Russian Journal of Stomatology. 2026;(1-2):158-164
Abstract:

The paper reviews the diagnostic possibilities of different methods for the evaluation of liver fibrosis in chronic viral hepatitis from the point of view of their clinical application. Histological examination retains its value as the gold standard method in evaluating the liver. Transient elastography is a rather effective tool for identifying severe liver fibrosis.

Keywords:

chronic viral hepatitis
fibrosis
biopsy
noninvasive methods

Authors:

Navrotskiĭ A.N.

GBOU VPO "Omskaia gosudarstvennaia meditsinskaia akademiia" Minzdrava Rossii

Close metadata

References:

  1. Isakov V. How to determine the severity of liver fibrosis, and why? Klinicheskaya gastroenterologiya i gepatologiya Russkoe izdanie. 2008;1(2):72-75. (In Russ.)
  2. Pavlov Ch, Glushenkov D, Ivashkin V. Modern potentials of elastometry, fibro-and acti-test in diagnostics of liver fibrosis. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2008;18(4):43-52. (In Russ.)
  3. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42(1):S22-S36. doi:10.1016/j.jhep.2004.12.008
  4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology; 1981;1:431-435. doi:10.1002/hep.1840010511
  5. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips M, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699. doi:10.1016/0168-8278(95)80226-6
  6. Desmet V. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 1994;19(6):1513-1520. doi:10.1016/0270-9139(94)90250-x
  7. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372-374. doi:10.1016/0168-8278(91)90084-o
  8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24(2):289-293. doi:10.1002/hep.510240201
  9. Mannan R, Misra V, Misra SP, Singh PA, Dwivedi M. A Comparative Evaluation of Scoring Systems in Liver Biopsies of Patients with Chronic Viral Hepatitis. J Clin Diagn Res. 2014;8(8).FC08-FC12. doi:10.7860/JCDR/2014/8704.4718
  10. Serov V, Severgina L. Morphological criteria for the assesment of etiology, degree of activity and stage of the disease in viral chronic hepatitis B and C. Arkhiv patologii. 1996;58(4):61-64. (In Russ.)
  11. Pinzani M. The evolution of liver fibrosis: from hepatitis to cirrhosis. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2002;XII(5):4-9. (In Russ.)
  12. Romanova E. Clinical and immunological and immunogenetic aspects of fibrogenesis in the liver in chronic hepatitis C. 2008. (In Russ.) Available at: http://www.crie.ru/pdf/avtoref1%28romanova%29.pdf
  13. Goodman Z, Becker R, Pockros P, Afdhal N. Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis. Hepatology. 2007;45(4):886-894. doi:10.1002/hep.21595
  14. Kweon Y, Goodman Z, Dienstag J et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol. 2001;35(6):749-755. doi:10.1016/s0168-8278(01)00218-5
  15. Afdhal N, Nunes D. Evaluation of Liver Fibrosis: A Concise Review. Am J Gastroenterol. 2004;99(6):1160-1174. doi:10.1111/j.1572-0241.2004.30110.x
  16. Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res. 2008;38(8):762-769. doi:10.1111/j.1872-034x.2008.00364.x
  17. Christiansen K, Mössner B, Hansen J, Jarnbjer E, Pedersen C, Christensen P. Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study. PLoS ONE. 2014;9(11):e111912. doi:10.1371/journal.pone.0111912
  18. Levine R, Sanderson S, Ploutz-Snyder R et al. Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D. Clin Gastroenterol Hepatol. 2006;4(10):1271-1277. doi:10.1016/j.cgh.2006.05.028
  19. Nepomnyashchikh G, Aidagulova S, Nepomnyashchikh D, Nokhrina Z, Vinogradova E, Karavayeva J. Morphogenesis of chronic hepatitis C and liver cirrosis of inflectional-viral genesis. Bjulleten' SO RAMN. 2008;28(6):66-77. (In Russ.)
  20. Bani-Sadr F, Lapidus N, Bedossa P et al. Progression of Fibrosis in HIV and Hepatitis C Virus-Coinfected Patients Treated with Interferon plus Ribavirin-Based Therapy: Analysis of Risk Factors. Clin Infect Dis. 2008;46(5):768-774. doi:10.1086/527565
  21. Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD. Chung R.T. Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). JAIDS. 2010;55(5):597-605. doi:10.1097/qai.0b013e3181f6d916
  22. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon. New Engl J Med. 2008;359(23):2429-2441. doi:10.1056/nejmoa0707615
  23. Ono E. Platelet count reflects stage of chronic hepatitis C. Hepatol Res. 1999;15(3):192-200. doi:10.1016/s1386-6346(98)00075-8
  24. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41(6):1376-1382. doi:10.1002/hep.20717
  25. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz MLG, Silva AEB. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int. 2008;28(4):486-493. doi:10.1111/j.1478-3231.2008.01675.x
  26. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32-36. doi:10.1002/hep.21669
  27. Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruíz-Morales J, Lomas-Cabeza JM, García-García JA, Corzo JE, Pineda JA. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006;55(3):409-414. doi:10.1136/gut.2005.065904
  28. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology. 2005;42(2):282-292. doi:10.1002/hep.20772
  29. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36(4):986-992. doi:10.1053/jhep.2002.36128
  30. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45(2):297-306. doi:10.1002/hep.21520
  31. Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepatitis. 2008;15(6):474-474. doi:10.1111/j.1365-2893.2008.00987.x
  32. Leroy V, Hilleret M, Sturm N, Trocme C, Renversez J, Faure P, Morel F, Zarski J. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46(5):775-782. doi:10.1016/j.jhep.2006.12.013
  33. Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003;37(5):1220-1221. doi:10.1053/jhep.2003.50109
  34. Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, Poynard T. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology. 2004;39(3):862-863. doi:10.1002/hep.20099
  35. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007;7(1):40. doi:10.1186/1471-230x-7-40
  36. Boursier J, Bacq Y, Halfon P, Leroy V, de Ledinghen V, de Muret A, Bourlière M, Sturm N, Foucher J, Oberti F, Rousselet MC, Calès P. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21(1):28-38. doi:10.1097/meg.0b013e32830cebd7
  37. Calès P, Boursier J, de Lédinghen V, Halfon P, Bacq Y, Leroy V, Dib N, Oberti F, Sawadogo A, Rousselet M, Lunel F. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroentérol Clin Biol. 2008;32(12):1050-1060. doi:10.1016/j.gcb.2008.09.017
  38. Calès P, De Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, De Muret A, Sturm N, Hunault G, Oberti F. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int. 2008;28(10):1352-1362. doi:10.1111/j.1478-3231.2008.01789.x
  39. Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourlière M, de Muret A, Sturm N, Hunault G, Penaranda G, Bréchot M, Trocme C, Calès P. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual data. Clin Biochem. 2008;41(16-17):1368-1376. doi:10.1016/j.clinbiochem.2008.06.020
  40. Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of Simple Biochemical Tests in Identifying Liver Fibrosis in Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clin Gastroenterol Hepatol. 2009;7(3):339-345. doi:10.1016/j.cgh.2008.11.019
  41. Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study — ANRS HC02. J Hepatol. 2008;48(5):765-773. doi:10.1016/j.jhep.2008.01.025
  42. Bottero J, Lacombe K, Guéchot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina J, Lascoux-Combe C, Girard P. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50(6):1074-1083. doi:10.1016/j.jhep.2009.01.022
  43. Patel K, Nelson D, Rockey D, Afdhal N, Smith K, Oh E, Hettinger K, Vallée M, Dev A, Smith-Riggs M, McHutchison J. Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C. Clin Gastroenterol Hepatol. 2008;6(2):242-247. doi:10.1016/j.cgh.2007.11.009
  44. Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky J, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004;41(6):935-942. doi:10.1016/j.jhep.2004.08.008
  45. Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO Spect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepatitis. 2009;16(3):178-186. doi:10.1111/j.1365-2893.2008.01062.x
  46. Kuznecova A, Zherdeva A, Gorovenko N, Dubotolkina E, Lojfman E. Place and role of serum markers of fibrosis in the diagnosis and treatment of chronic HCV-infection. Klinicheskie perspektivy gastrojenterologii, gepatologii. 2007;3:35-39. (In Russ.)
  47. Halfon P, Bourlière M, Pénaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A, Ouzan D. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005;4:6. doi:10.1186/1476-5926-4-6
  48. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterology. 2005;5:32. doi:10.1186/1471-230X-5-32
  49. White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P, Gattu M, Rockey DC, Berrey M, McHutchison JG. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Translational Med. 2007;5(1):33. doi:10.1186/1479-5876-5-33
  50. Romagnuolo J. Predicting the liver histology in chronic hepatitis C: how good is the clinician? Am J Gastroenterol. 2001;96(11):3165-3174. doi:10.1016/s0002-9270(01)03837-0
  51. Castera L. Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C. Gastroenterology. 2012;142(6):1293-1302.e4. doi:10.1053/j.gastro.2012.02.017
  52. Degos F, Perez P, Asselineau J, Bedossa P. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol. 2011;55(1):234-235. doi:10.1016/j.jhep.2011.01.015
  53. Talwalkar J, Kurtz D, Schoenleber S, West C, Montori V. Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214-1220. doi:10.1016/j.cgh.2007.07.020
  54. Dudina K, Znojko O, Shut'ko S, Kozina A, Jushhuk N. Comparative analysis of invasive and non-invasive diagnosis of liver fibrosis in patients with chronic hepatitis B. Vrach. 2011;(10):57-59. (In Russ.)
  55. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data. Clin Gastroenterol Hepatol. 2015;13(3):440-451.e6. doi:10.1016/j.cgh.2014.09.046
  56. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL. Ocenka vyrazhennosti fibroza pecheni s pomoshh'ju magnitno-rezonansnoj jelastografii. Klinicheskaja gastrojenterologija i gepatologija. Russkoe izdanie. 2008;1(2):92-100.
  57. Lewin M, Poujol-Robert A, Boëlle P, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana J, Poupon R. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46(3):658-665. doi:10.1002/hep.21747
  58. Rayevneva T. Visualization methods in diagnosis of fibrosis stage of chronic diffuse diseases of liver. Zdravoohranenie. 2012;(5):31-33. (In Russ.)
  59. Giannini EG, Fasoli A, Borro P, Botta F, Malfatti F, Fumagalli A, Testa E, Polegato S, Cotellessa T, Milazzo S, Risso D, Testa R. Primenenie jekspiratornyh prob s S-galaktozoj i S-aminopirinom dlja ocenki funkcii pecheni pri hronicheskih zabolevanijah pecheni. Klinicheskaja gastrojenterologija i gepatologija. Russkoe izdanie. 2008;1(2):110-116.
  60. Ivkova A.N., Il'chenko L.Ju., Kushlinskij N.E., Storozhakov G.I. The content of growth factors in the serum of patients with chronic hepatitis C and C-induced liver cirrhosis. Mir virusnyh gepatitov. 2008;10(2):5-8. Accessed October 14, 2015. Available at: http://astro- sirius.ru/hi0208/hi0208.pdf (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.